PALO ALTO, Calif., June 09, 2017 -- Medable Inc.--the leading app and analytics platform for healthcare--today announced the release of Synapse, the first cloud solution to enable Apple’s new CareKit Bridge APIs for real time health management on iOS.
Synapse enables healthcare organizations to seamlessly launch CareKit apps for not only their patients but now for their care teams. Synapse allows providers and patients to track and trend health in real-time, addressing the massive cost issues from poor communication, including preventable readmissions. In addition to app creation, Synapse provides user and data management, HIPAA compliance, EMR interoperability, and outcomes analytics. Early use cases include clinical trials, chronic disease management, and post-op care. For example, a post-operative care app for hip replacement that enables a patient to track pain medication usage, monitor for surgical site infection, track mobility metrics, and communicate with the care team, all from the comfort of the patient’s own home.
“Too often the care delivered within the walls of hospitals is undermined by a lack of clear guidance for patients after visits,” said Dr. Michelle Longmire, Medable CEO. “Medable’s platform, built using CareKit, allows healthcare organizations to open the door for clear and continuous care, anytime, anywhere.”
Longmire said Medable is working with leading healthcare institutions to bring its advanced technology to the forefront of patient management.
“CareKit is a powerful tool for improving health outcomes and is a practical solution for harnessing innovation to address huge, long standing problems in healthcare,” said Longmire. “As an industry, healthcare is realizing the power of mobile as a conduit for better healthcare.”
For more information about Synapse: www.medable.com/synapse
ABOUT MEDABLE
Privately-held Palo Alto, California-based Medable provides a comprehensive, secure HIPAA-compliant cloud-based platform purpose-built for healthcare. Medable’s Synapse is a clinical care app solution for providers and patients. Medable’s award-winning Cortex is the fastest way for developers to create scalable, EHR interoperable, HIPAA compliant applications. Medable’s Axon is a “no coding required” solution enabling researchers to deliver smartphone clinical studies on a secure, HIPAA compliant technology stack. Medable’s Cerebrum is the first cloud-based machine learning solution created specifically for healthcare apps. For more information visit: www.medable.com
Follow Medable on Twitter: @medableinc
Gary Poole, PR Director [email protected]


Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
CK Hutchison Unit Launches Arbitration Against Panama Over Port Concessions Ruling
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Qantas to Sell Jetstar Japan Stake as It Refocuses on Core Australian Operations 



